|
|
|
Following storm damage from Hurricane Helene at Baxter International Inc.’s facility in North Carolina, the U.S. Department of Health and Human Services and its subagencies continue taking action to support access to intravenous fluids, including ensuring restoration of key production sites, protecting products, and opening imports, in partnership with manufacturers, distributors, hospitals, and other stakeholders. As a result of these steps, hospitals have 50% more product available to them now compared to right after the hurricane.
|
|
HHS News Release (10/18/24)
|
|
|
|
Last week, ASCA released its latest 60-Second Survey asking a few questions about your facility’s operations with regards to anesthesia providers. As always, these surveys are designed to take approximately one minute, so you won’t need to pull any reports to respond. This survey will be open through this Friday, October 25. Take the survey now! |
|
ASCA Content (10/22/24)
|
|
Deterra is the Solution for Safe Medication DisposalProviders and patients can destroy unused medications quickly and easily with Deterra® Drug Deactivation and Disposal Pouches. Read testimonials and learn how you can order case quantities of pouches for healthcare use.
|
|
|
|
An intravenous (IV) solutions shortage has gripped the nation since Hurricane Helene made its landfall on September 26. Much of the shortage is due to Baxter’s manufacturing site in North Cove, North Carolina, shutting down production after Helene’s rain and storm surge flooded the facility. This Baxter facility supplies approximately 60 percent of the IV solutions used every day in the US. Read this Digital Debut to learn more. |
|
ASCA Content (10/22/24)
|
|
Top-Quality Procedure Trays from PAJUNKPajunk USA provides a comprehensive selection of procedural trays tailored for regional anesthesia and pain management needs. Our offerings include Single-Shot, CPNB, Spinal, Epidural and CSE, as well as custom and support trays. Learn more.
|
|
|
|
|
Medicare reform appears to have bipartisan support in the U.S. House of Representatives, with 233 Republicans and Democrats signing a letter that calls on leadership to block Medicare reimbursement cuts. In July, the Centers for Medicare & Medicaid Services proposed cuts that would reduce reimbursement rates for care delivered to Medicare patients by 2.8% in the 2025 physician fee schedule.
|
|
HealthExec (10/18/24) Chad Van Alstin
|
|
2024 ASC Industry Report Now Available: The 2024 State of the Industry Report is live, with data from 590+ ASCs across 47 states. Read the report now and schedule a demo to learn how HST can help you meet and exceed industry standards.
|
|
|
|
Renew your ASCA membership today for uninterrupted access to many benefits, including virtual education and essential OAS CAHPS Survey resources. Your 2024 membership expires on December 31. Renew before December 20 to receive your 2025 membership certificate in January.
|
|
ASCA Content (10/22/24)
|
|
|
Versatility in every drop: With its low-foam, pH-neutral, ultra-concentrated formulation, XEN Enzymatic+ delivers superb control for cleaning a wide range of medical instruments, including your most intricate devices.
|
|
|
|
|
Harvard Medical School is bringing artificial intelligence into its curriculum. For the first time this fall, students starting a health science and technology track will take a one-month introductory course on AI in health care.
|
|
Politico (10/17/24) Daniel Payne; Ruth Reader; Erin Schumaker
|
|
Get Compliance Peace of MindWith an incomplete picture of compliance and credentialing, your risks are higher, you’re reactive, and you have a greater chance of penalties. Check out these nine reports to determine if your current reporting is making the grade. If not, consider an alternative solution that will deliver peace of mind.
|
|
|
|
Join us April 30–May 3 in Denver, Colorado, for the ASCA 2025 Conference & Expo! ASCA 2025 is the premier ASC event of the year, offering the most impactful, high-quality and cost-effective education as well as ample networking opportunities for attendees, speakers and exhibitors. Register now to get the best rate! |
|
ASCA Content (10/22/24)
|
|
|
|
|
This monograph features the clinical perspectives from those working in the trenches of postsurgical pain management, and addresses how their institutions are preparing for a new separate Medicare reimbursement for certain branded non-opioid analgesics for procedures in the hospital outpatient and ambulatory settings.
|
|
General Surgery News (10/14/24) Jon Albrecht; Eric S. Bour; Christopher Fox; et al.
|
|
|
|
Data submission for the third quarter (Q3) of ASCA’s 2024 Clinical & Operational Benchmarking Survey is due Thursday, October 31. This valuable online resource provides data you can use to improve clinical outcomes, staff indicators, billing performance and more at your facility. If you haven’t already, subscribe today so you can submit your data and receive comparison data for the remainder of the year. |
|
ASCA Content (10/22/24)
|
|
|
|
|
Epidemiological studies have long suggested strong effects of screening colonoscopy in preventing colorectal cancer. However, much weaker than expected effects were reported in 2022 from the NordICC trial, the first and so far only randomized clinical trial reporting on long-term effects of screening colonoscopy, to our knowledge.
|
|
JAMA Network Open (10/01/24) Hermann Brenner; Thomas Heisser; Michael Hoffmeister
|
|
About ASCAMission: The Ambulatory Surgery Center Association (ASCA) is the national membership association that represents ambulatory surgery centers (ASCs) and provides advocacy and resources to assist ASCs in delivering high-quality, cost-effective ambulatory surgery to all the patients they serve. About Us: At ASCA, we are eager to help you become better acquainted with our nation's ASCs and the people who own and operate them. We are also eager to help you develop policies on ASC-related issues. If you have questions, please contact us. We'll put you in touch with the experts and, if you like, arrange for you to visit an ASC in your area. Contact Us: Advertising inquiries should be addressed to Chris Schriever or Alex Yewdell at 202.337.1897 or at advertising@ascassociation.org. Follow ASCA on
|
|
|
|
|